DoD Rare Cancers, Resource and Community Development Award
Department of Defense
Description
The FY25 Rare Cancers Research Program (RCRP) Resource and Community Development Award (RCDA) aims to improve rare cancer research and outcomes by addressing key gaps. These include the lack of research resources (like patient tissues and tumor models), poor communication strategies for sharing research findings, insufficient data-sharing infrastructure, and limited treatment research. The award requires engaging Patient Advocates throughout the research process, emphasizes community buildin…
Summary: The fiscal year 2025 (FY25) Rare Cancers Research Program (RCRP) Resource and Community Development Award (RCDA) supports the development of research resources and clinical or preclinical data sets that will advance the field of rare cancers research and ultimately impr…
Source
Grant ID
HT942525RCRPRCDA
Agency
Department of Defense
Subcategory/Subagency
Dept. of the Army -- USAMRAA
Key Dates
Solicitation Posted
May 1, 2025
Application Response Due
October 6, 2025
Eligibility
The following categories of applicants are invited to apply:
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Awards & Funding
Total Funding
$5.6M
Funding Amount
Discretionary
Links
Documents
Similar opportunities
- Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
Department of Health and Human Services
- NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
Department of Health and Human Services
- DoD Rare Cancers, Idea Development Award
Department of Defense
- Forecast to Publish a Notice of Funding Opportunity (NOFO) for NCI Community Oncology Research Program (NCORP) Academic Community Sites (UG1 Clinical Trials Not Allowed)
Department of Health and Human Services
- Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
Department of Health and Human Services